These findings suggest that FGFR4 facilitates fatty acid metabolism remodeling by activating the downstream PI3K-Akt pathway and upregulating FASN expression, thereby promoting the initiation and progression of colorectal cancer. Here, FGFR4 is linked to colorectal cancer.